HBV/HDV-IN-1

• UNSPSC Description:

  HBV/HDV-IN-1 (Compd 122) is a HBV, HDV and PD-1/PD-L1 inhibitor, with EC50 values of 8 nM for T cell activation and 35 nM for PD-L1 internalization[1].

• Target Antigen:

  HBV; PD-1/PD-L1

• Type:

  Reference compound

• Related Pathways:

  Anti-infection;Immunology/Inflammation

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Cancer; Infection; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/hbv-hdv-in-1.html

• Smiles:

  O=C(NC1=CC=CC(C2=NC=CC(C3=NC(OC)=C(CNC[C@H](CC4)NC4=O)C=C3)=C2Cl)=C1Cl)C5=NC=C(CNC6CCN(C(C)=O)CC6)C(OC)=C5

• Molecular Weight:

  761.70

• References & Citations:

  [1]Andrew G. Cole, et al. Substituted 1-arylaminocarbonyl-1'-heteroaryl compounds, substituted 1-heteroarylaminocarbonyl-1'-heteroaryl compounds and methods using same. Patent. WO2024069448A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  3034161-55-9